These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 33130103)

  • 1. The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection.
    Penninger JM; Grant MB; Sung JJY
    Gastroenterology; 2021 Jan; 160(1):39-46. PubMed ID: 33130103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019).
    Foroozanfar E; Forouzanfar M; Farkhondeh T; Samarghandian S; Forouzanfar F
    Curr Drug Discov Technol; 2021; 18(6):e130921189567. PubMed ID: 33371835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance.
    Ferrara F; Vitiello A
    Cardiovasc Toxicol; 2021 Jun; 21(6):498-503. PubMed ID: 33835386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
    Suárez-Fariñas M; Tokuyama M; Wei G; Huang R; Livanos A; Jha D; Levescot A; Irizar H; Kosoy R; Cording S; Wang W; Losic B; Ungaro RC; Di'Narzo A; Martinez-Delgado G; Suprun M; Corley MJ; Stojmirovic A; Houten SM; Peters L; Curran M; Brodmerkel C; Perrigoue J; Friedman JR; Hao K; Schadt EE; Zhu J; Ko HM; Cho J; Dubinsky MC; Sands BE; Ndhlovu L; Cerf-Bensusan N; Kasarskis A; Colombel JF; Harpaz N; Argmann C; Mehandru S
    Gastroenterology; 2021 Jan; 160(1):287-301.e20. PubMed ID: 32980345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
    Suh SH; Ma SK; Kim SW; Bae EH
    Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections.
    Ferrara F; Vitiello A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1589-1593. PubMed ID: 34151392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
    Galanopoulos M; Doukatas A; Gazouli M
    World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on ACE2 amplification and its therapeutic potential.
    Marquez A; Wysocki J; Pandit J; Batlle D
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13513. PubMed ID: 32469114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
    Guney C; Akar F
    J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
    Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
    Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
    Patankar JV; Chiriac MT; Lehmann M; Kühl AA; Atreya R; Becker C; ; Gonzalez-Acera M; Schmitt H; Gamez-Belmonte R; Mahapatro M; Diemand L; Hartmann L; Mascia F; Hracsko Z; Thonn V; Schödel L; Zielinska M; Yu Y; Erkert L; Li W; Zeitler M; Ruder B; Ganzleben I; Günther C; Voehringer D; Zundler S; Neurath MF; Siegmund B
    Gastroenterology; 2021 Feb; 160(3):925-928.e4. PubMed ID: 33075345
    [No Abstract]   [Full Text] [Related]  

  • 14. Physiological implications of COVID-19 in reproduction: angiotensin-converting enzyme 2 a key player.
    Sharma GT; Chandra V; Mankuzhy P; Thirupathi Y; Swain DK; Pillai H; Patel SK; Pathak M; Guttula S
    Reprod Fertil Dev; 2021 Apr; 33(6):381-391. PubMed ID: 33731252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In search of preventive strategies: novel high-CBD
    Wang B; Kovalchuk A; Li D; Rodriguez-Juarez R; Ilnytskyy Y; Kovalchuk I; Kovalchuk O
    Aging (Albany NY); 2020 Nov; 12(22):22425-22444. PubMed ID: 33221759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
    Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
    Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
    Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment.
    Kate Gadanec L; Qaradakhi T; Renee McSweeney K; Ashiana Ali B; Zulli A; Apostolopoulos V
    Future Microbiol; 2021 Mar; 16():205-209. PubMed ID: 33569984
    [No Abstract]   [Full Text] [Related]  

  • 20. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.